Hongfang Yu

Also affiliated with University of Electronic Science and Technology of China, University of Massachusetts Amherst, Beijing Shijingshan Hospital

Computer ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluation of Epigallocatechin-3-Gallate-Palmitate (EC16) in Nasal Formulations Against Human Coronavirus”.

Evaluation of Epigallocatechin-3-Gallate-Palmitate (EC16) in Nasal Formulations Against Human Coronavirus

Preprints.org(2023)10.20944/preprints202304.0192.v1

N/A

0DataRank · unranked

3 citations

Douglas Dickinson, William J. Garcia, Lucee Xiao, Andra Xayaraj, Learn−Han Lee +8 more

Feasibility Study of Developing a Saline-Based Antiviral Nanoformulation Containing Lipid-Soluble EGCG: A Potential Nasal Drug to Treat Long COVID

Viruses(2024)10.3390/v16020196

N/A

0DataRank · unranked

6 citations

Douglas Dickinson, William J. Garcia, Yutao Liu, Hongfang Yu, Jingwen Cai +5 more

Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment

Pharmaceutics(2024)10.3390/pharmaceutics16060791

N/A

0DataRank · unranked

3 citations

Douglas Dickinson, Garrison Lovett, Yutao Liu, Hongfang Yu, Jingwen Cai +4 more